fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search

Israel is Chosen to Participate in International Clinical Study to Test a Cure for Covid-19

Test a Cure for COVID-19
Eight countries in the world were selected to partake in clinical research trials on the drug Kevzara, already in use as a medication for rheumatoid arthritis. The two-month study will involve 40 patients in Israel and about 300 internationally.

Presently, there are few and limited treatments available for patients infected with COVIDd-19, and all of these treatments are unproven and experimental. The study on Kevzara marks Israel’s first clinical research trial to identify an effective medical treatment.

In Israel, the drug will be administered at Sheba Medical Center, Assuta Medical Center in Ashdod, and Hadassah Ein Kerem Hospital in Jerusalem. Earlier this week, a 64-year-old woman hospitalized at Sheba Medical Center in moderate condition became the first coronavirus in Israel to receive Kevzara as a treatment for her symptoms.

Kevzara is manufactured by the French company Sanofi, and it was decided to test this drug after coronavirus patients in China were given a similar drug (not in the framework of a clinical study) and exhibited a positive response.

Until now, critically ill coronavirus patients in Israel have been given experimental drugs within the classification of being a “compassionate treatment.” Drugs in this category are not designed specifically to treat the disease, which makes it almost impossible to know which medication had an effect (or did not have any effect) on improving their condition. In contrast, the new clinical study on Kevzara will examine the safety of the drug in a controlled environment – enabling doctors to comprehensively analyze its effectiveness and safety.

Related
EBMT 50th Anniversary: Prof. Arnon Nagler Shares Expertise
Prof. Nagler attended the EBMT's 50th meeting, discussing bone marrow transplantation, donor selection, and treatment optimization in a series of interviews.
Read More
A Heartfelt Journey: Baby Marios’s Triumph Over Adversity
Six-month-old Marios Fesas, born in Cyprus, embarked on a harrowing journey when diagnosed with a critical heart defect just days after birth. With unwavering hope,…
Read More
Designing for Wellness: Place2Heal's Vision for Pediatric Care
At Sheba’s Edmond and Lily Safra Children’s Hospital, comforting and preparing young patients for medical procedures remains integral to their care. The formidable nature of…
Read More